Bert Labs strengthens its pharma capabilities with senior-level appointments

Bert Labs yesterday announced that it has appointed Dr Dinabandhu Naskar as Director and Bert Evangelist, Pharma Research; Dr Rudresha Prasad as Director and Bert Evangelist, Pharma Manufacturing, and Shailendra Borole as Bert Evangelist, Pharma Engineering.

In a statement, Bert Labs said that the appointments come as the company continues to explore applications of Bert platform solution in several industry verticals and in-line with its domain-led growth strategy.

Welcoming the newly-formed Bert Pharma team, Rohit Kochar, Founder, Executive Chairman and CEO, Bert Labs, said in the statement, “At Bert Labs, we are thrilled to build Bert Pharma team to address the core issues for our clients and build proficiency. Bert journey is of research and innovation, uncompromisable integrity and value systems, and entrepreneurial leadership. We are here to build Bert Labs into one of the leading global technology conglomerates and these decisive appointments showcase our commitment, capability and willingness to solve complex problems for our clients and enabling their innovation for higher quality drugs, and be more capital efficient, profitable, and smarter with their customers.”

Adding to it, Dr Dinabandhu Naskar, Director and Bert Evangelist – Pharma Research, said in the statement, “I am fortunate to take on this new responsibility and looking forward to work with our clients in drug discovery and development process. With a specialty team in place, we will be able to provide the best of service with custom-made solutions to our pharma clients. I am here to make a difference and to be at the forefront of innovation, as we collaborate with pharma, biotech and research institutes across the globe to deliver recurring value to each one of our customers.”

The statement notified that Dr Naskar was VP, Syngene in his over 20 years of experience as Lead Investigator and Senior Scientist in drug discovery and development. He has PhD from Indian Institute of Chemical Technology, Hyderabad and post-doctoral fellowship from the University of Gottingen, in Germany.

Dr Rudresha Prasad, Director and Bert Evangelist – Pharma Manufacturing, was VP, GSK, and was responsible for technical process of all manufacturing plants in India. He has PhD from IISc and two post-doctoral fellowships from the University of Strathclyde and Oxford University. Shailendra Borole is Utility Expert, Bert Pharma HVAC. He was responsible for 21 years for Projects and Engineering at Cipla, the statement added.